Cancer-fighting Nanorobots to Shrink Tumors

by Colleen Fleiss on  February 13, 2018 at 11:20 PM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

In a major advancement in nanomedicine, nanorobots were programmed to target and destroy tumors.

Each nanorobot is made from a flat, rectangular DNA origami sheet that is 90 nanometres by 60 nanometres in size.
Cancer-fighting Nanorobots to Shrink Tumors
Cancer-fighting Nanorobots to Shrink Tumors

Once bound to the tumor blood vessel surface, the nanorobot was programmed to deliver its unsuspecting drug cargo in the very heart of the tumor, exposing an enzyme called thrombin that is key to blood clotting.

Show Full Article


The nanorobots worked fast, congregating in large numbers to quickly surround the tumor just hours after injection.

The treatment blocked blood supply to the tumor and generated tumor tissue damage within 24 hours while having no effect on healthy tissues.

After attacking tumors, most of the nanorobots were cleared and degraded from the body after 24 hours.

The median survival time is more than doubled, extending from 20.5 to 45 days.

"Moreover, this technology is a strategy that can be used for many types of cancer, since all solid tumor-feeding blood vessels are essentially the same," said Hao Yan, Professor and Director at Arizona State University, in a paper published in the journal Nature Biotechnology.

Until now, the challenge to advancing nanomedicine has been difficult because scientists wanted to design, build and carefully control nanorobots to actively seek and destroy cancerous tumors, while not harming any healthy cells.

However, the new "nanorobots can be programmed to transport molecular payloads and cause on-site tumor blood supply blockages, which can lead to tissue death and shrink the tumor", explained Baoquan Ding, Professor at the National Centre for Nanoscience and Technology (NCNST) in China.

For the study, the team used a melanoma mouse model, where the nanorobot not only affected the primary tumor but also prevented the formation of metastasis, showing promising therapeutic potential.

Importantly, the nanorobots were found safe and effective in shrinking tumors and there was no evidence of the nanorobots spreading into the brain where it could cause unwanted side-effects, such as a stroke.

"The thrombin delivery DNA nanorobot constitutes a major advance in the application of DNA nanotechnology for cancer therapy," Yan said.

Source: IANS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive